Pharmaceuticals (147) | Merger Agreements (147)

Browse by Company

4Front Ventures Corp. (5 contracts)
60 DEGREES PHARMACEUTICALS, INC. (1)
Acasti Pharma Inc. (1)
ACELRX PHARMACEUTICALS INC (3)
ACHILLION PHARMACEUTICALS INC (1)
Adamis Pharmaceuticals Corp (2)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (1)
Akers Biosciences, Inc. (1)
ALDER BIOPHARMACEUTICALS INC (1)
Amag Pharmaceuticals (1)
Angion Biomedica Corp. (1)
ANI Pharma Inc (3)
APRICUS BIOSCIENCES, INC. (1)
Assertio Therapeutics, Inc (3)
AYTU BIOSCIENCE, INC (3)
Big Rock Partners Acquisition Corp. (3)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
BioPharmX Corp (2)
Blue Water Acquisition Corp. (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (2)
Bright Green Corp (3)
Bristol-Myers Squibb (1)
Catalent Inc (2)
CELGENE CORP (1)
Cerecor Inc. (2)
CHIASMA, INC (1)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
COLLEGIUM PHARMACEUTICAL, INC (1)
ContraVir Pharmaceuticals, Inc. (1)
Cure Pharmaceutical Holding Corp. (2)
Dova Pharmaceuticals Inc. (1)
Egalet Corp (2)
Elanco Animal Health Inc (3)
Eloxx Pharmaceuticals, Inc. (1)
Endo International plc (1)
Foamix Pharmaceuticals Ltd. (2)
FRONTIER OILFIELD SERVICES INC (1)
GRAYBUG VISION, INC. (2)
Horizon Pharma plc (1)
Ikena Oncology, Inc. (2)
INNOVATE BIOPHARMACEUTICALS, INC. (2)
Innoviva, Inc. (2)
Intersect ENT, Inc. (1)
Item 9 Labs Corp. (3)
Johnson & Johnson (1)
Jushi Holdings Inc. (3)
Kala Pharmaceuticals, Inc. (1)
Level Brands, Inc. (5)
Liquidia Corp (2)
Marijuana Co of America, Inc. (2)
Medicine Man Technologies, Inc. (9)
Menlo Therapeutics Inc. (3)
MYnd Analytics, Inc. (2)
MyoKardia Inc (1)
Neos Therapeutics, Inc. (1)
Neuralstem, Inc. (1)
One World Pharma, Inc. (2)
Pacira Pharmaceuticals, Inc. (2)
Perrigo (1)
Pfizer (1)
Phathom Pharmaceuticals, Inc. (1)
Provention Bio, Inc. (1)
Ra Pharmaceuticals, Inc. (1)
RespireRx Pharmaceuticals Inc. (1)
resTORbio, Inc. (1)
Roivant Sciences Ltd. (2)
Supernus Pharmaceuticals, Inc. (1)
Tenzing Acquisition Corp. (1)
Terra Tech Corp. (5)
TETRAPHASE PHARMACEUTICALS INC (7)
The Medicines Company (1)
TherapeuticsMD, Inc. (1)
Tilray, Inc. (1)
Trulieve Cannabis Corp. (1)
Urovant Sciences Ltd. (1)
Vallon Pharmaceuticals, Inc. (1)
Vitality Biopharma, Inc. (1)
ZOGENIX, INC. (2)

Recent Contracts

Agreement and Plan of Merger, by and among Pfizer Inc., Aris Merger Sub, Inc. and Seagen Inc., dated as of March 12, 2023 (Pfizer, Filed With SEC on March 13, 2023)
Agreement and Plan of Merger, dated as of March 12, 2023, among the Company, Parent and Purchaser (pursuant to Item 601(a)(5) of Regulation S-K, the Company hereby agrees to... (Provention Bio, Inc., Filed With SEC on March 13, 2023)
Form of Support Agreement, dated February 24, 2023, by and among Adamis Pharmaceuticals, Inc., Aardvark Merger Sub, Inc., DMK Pharmaceuticals Corporation, and certain stockholders... (Adamis Pharmaceuticals Corp, Filed With SEC on February 27, 2023)
Agreement and Plan of Merger and Reorganization, dated as of February 24, 2023, by and among Adamis Pharmaceuticals, Inc., Adamis Merger Sub, Inc., and DMK Pharmaceuticals... (Adamis Pharmaceuticals Corp, Filed With SEC on February 27, 2023)
Amendment to Agreement and Plan of Merger, dated as of February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc., and Vallon Merger Sub, Inc (Vallon Pharmaceuticals, Inc., Filed With SEC on February 24, 2023)
First Amendment to the Agreement and Plan of Merger and Reorganization, dated November 21, 2022, by and among CalciMedica, Inc., Camaro Merger Sub, Inc. and Graybug Vision, Inc.,... (GRAYBUG VISION, INC., Filed With SEC on February 16, 2023)
Agreement and Plan of Merger dated as of June 1, 2022, by and between the Registrant and 60 Degrees Pharmaceuticals, LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on January 31, 2023)
Agreement and Plan of Merger and Reorganization, dated January 17, 2023, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc (Angion Biomedica Corp., Filed With SEC on January 17, 2023)
Agreement and Plan of Merger, dated as of January 8, 2023, by and among CinCor Pharma, Inc., AstraZeneca Finance and Holdings Inc. and Cinnamon Acquisition, Inc (CinCor Pharma, Inc., Filed With SEC on January 9, 2023)
Agreement and Plan of Merger between Body and Mind Inc., DEP Nevada, Inc., BaM Body and Mind Dispensary NJ, Inc., CraftedPlants NJ Corp. and the shareholders of CraftedPlants NJ... (BODY & MIND INC., Filed With SEC on December 23, 2022)
Agreement and Plan of Merger and Reorganization, dated November 21, 2022, by and among the CalciMedica, Inc., Camaro Merger Sub, Inc. and Graybug Vision, Inc (GRAYBUG VISION, INC., Filed With SEC on November 22, 2022)
Agreement and Plan of Merger, dated as of October 31, 2022, by and among Johnson & Johnson, Athos Merger Sub, Inc. and ABIOMED, Inc (Johnson & Johnson, Filed With SEC on November 1, 2022)
Agreement and Plan of Merger, dated as of August 22, 2022, by and among the Company, Parent and Merger Sub (AERIE PHARMACEUTICALS INC, Filed With SEC on August 23, 2022)
Second Amendment to Merger and Membership Interest Purchase Agreement, dated September 7, 2021, by and between Sammartino Investments LLC Jushi Inc (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
First Amendment to Merger and Membership Interest Purchase Agreement, dated May 13, 2021, by and between Sammartino Investments LLC Jushi Inc (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
Merger and Membership Interest Purchase Agreement, dated April 16, 2021, by and among Jushi MA, Inc., Jushi Inc, Jushi Holdings Inc., Sammartino Investments LLC, Natures Remedy of... (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
Agreement and Plan of Merger, dated as of July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., and La Jolla Pharmaceutical Company (Innoviva, Inc., Filed With SEC on July 11, 2022)
Form of Warrant assumed as part of the Nanomix Merger (Boston Therapeutics, Inc., Filed With SEC on July 6, 2022)
Amendment No. 1 to the Business Combination Agreement, dated June 9, 2021, by and among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd. and Rhine Merger Sub, Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Business Combination Agreement, dated as of May 1, 2021, by and among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd. and Rhine Merger Sub, Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Agreement and Plan of Merger, dated as of May 27, 2022, among TherapeuticsMD, Inc., Athene Parent, Inc. and Athene Merger Sub, Inc (TherapeuticsMD, Inc., Filed With SEC on May 31, 2022)
Agreement and Plan of Merger, dated as of May 23, 2022, by and among Innoviva, Inc., Innoviva Merger Sub, Inc., and Entasis Therapeutics Holdings Inc (Innoviva, Inc., Filed With SEC on May 24, 2022)
Agreement and Plan of Merger between Bright Green Corporation and Naseeb Inc. dated as of November 10, 2020 (Bright Green Corp, Filed With SEC on May 5, 2022)
Agreement and Plan of Merger between Bright Green Corporation and Grants Greenhouse Growers Inc. dated as of October 30, 2020 (Bright Green Corp, Filed With SEC on May 5, 2022)
Agreement and Plan of Merger between Bright Green Corporation and Bright Green Grown Innovation LLC dated May 28, 2019 (Bright Green Corp, Filed With SEC on May 5, 2022)
Form of Merger Note (4Front Ventures Corp., Filed With SEC on April 22, 2022)
Amendment to Agreement and Plan of Merger by and among 4Front Ventures Corp., Island Merger Sub, Inc., Island Global Holdings, Inc., and Navy Capital SR LLC, dated April 8, 2022 (4Front Ventures Corp., Filed With SEC on April 22, 2022)
Agreement and Plan of Merger, dated as of March 30, by and among 4Front Ventures Corp., Island Merger Sub, Inc., Island Global Holdings, Inc., and Navy Capital SR LLC. Press... (4Front Ventures Corp., Filed With SEC on April 6, 2022)
Second Amendment to Rider to Contract to Buy and Sell Real Estate by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Contract to Buy and Sell Real Estate (Commercial), dated January 26, 2022, by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Agreement and Plan of Merger, dated as of February 14, 2022, by and among Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and BioDelivery Sciences International,... (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on February 15, 2022)
Amendment No. 1 to Agreement and Plan of Merger, dated February 9, 2022, by and among Medicine Man Technologies, Inc., Emerald Fields Merger Sub, LLC, MCG, LLC, the Members of... (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Bill of Sale and Assignment and Assumption Agreement, dated February 9, 2022, by and between Emerald Fields Merger Sub, LLC and 1508 Management, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Rider to Contract to Buy and Sell Real Estate by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Amendment to Rider to Contract to Buy and Sell Real Estate by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Agreement and Plan of Merger, dated as of February 14, 2022, by and among Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and BioDelivery Sciences International,... (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on February 14, 2022)
Agreement and Plan of Merger, dated as of February 14, 2022, by and among Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and BioDelivery Sciences International,... (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on February 14, 2022)
First Amendment to Agreement and Plan of Merger, dated as of January 28, 2022, by and among 4Front Ventures Corp., New England Cannabis Corporation, Inc., Kenneth V. Stevens, and... (4Front Ventures Corp., Filed With SEC on February 3, 2022)
Agreement and Plan of Merger, dated January 18, 2022, among UCB S.A., Zinc Merger Sub, Inc. and Zogenix, Inc (ZOGENIX, INC., Filed With SEC on January 19, 2022)
Form of Amendment No. 1 to the Merger Agreement, dated November 24, 2021, by and among Marijuana Company of America, Inc. and cDistro, Inc (Marijuana Co of America, Inc., Filed With SEC on December 1, 2021)